Skip to content
OpenCapital
Get started

PROCEPT BioRobotics Corporation PRCT Financing Cash Flow

Financing Cash Flow at other companies

TFX
TeleflexTFX
-$44.99M+24.4%
Boston Scientific logo
Boston ScientificBSX
-$260M-212%
Intuitive Surgical logo
Intuitive SurgicalISRG
-$1.35B-474%
Absci Corporation logo
Absci CorporationABSI
$7.56M-82.3%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$45.6M-159%
iRadimed logo
iRadimedIRMD
-$2.61M-14.4%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B—
P/S3.7×—

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's financing cash flow?
PROCEPT BioRobotics Corporation (PRCT) reported financing cash flow of $222K in Q1 2026.
How has PROCEPT BioRobotics Corporation's financing cash flow changed year-over-year?
PROCEPT BioRobotics Corporation's financing cash flow decreased by 82.9% year-over-year, from $1.3M to $222K.
What is the long-term trend for PROCEPT BioRobotics Corporation's financing cash flow?
Over 3 years (2021 to 2025), PROCEPT BioRobotics Corporation's financing cash flow has grown at a -65.0% compound annual growth rate (CAGR), from $262.12M to $11.19M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.